Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,616 recruiting studies in this area right now.
By phase
- Not applicable5,344
- Phase 2606
- Phase 1557
- Phase 3418
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity618
- Ovarian Cancer337
- Pancreatic Cancer287
- Type 2 Diabetes275
- Diabetes192
- Diabetes Mellitus182
- Diabetes Mellitus, Type 2171
- Hypertension138
- Type 1 Diabetes131
- Metabolic Syndrome127
- Obesity & Overweight125
- Breast Cancer111
- Cardiovascular Diseases105
- Overweight105
- Amyotrophic Lateral Sclerosis102
- Pancreas Cancer91
- Colorectal Cancer90
- Thyroid Cancer87
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center42
- Eli Lilly and Company41
- Massachusetts General Hospital41
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Johns Hopkins University38
Where studies are running
- California521
- Maryland180
- Alabama176
- Arizona170
- Florida166
- Texas159
- Massachusetts150
- New York144
- Colorado115
- Pennsylvania113
Recruiting studies7,616 total
- NCT07345494Recruiting
YORVIPATH pregnancy and breastfeeding safety study
This study tracks the health of mothers and babies who were exposed to YORVIPATH (a medicine for hypoparathyroidism) around the time of pregnancy or while breastfeeding. It aims to understand if the medicine affects pregnancy outcomes or infant health.
Morgantown, West VirginiaAges 15–50 - NCT07351058RecruitingPhase 3
Enicepatide for weight loss in people with type 2 diabetes
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
Guntersville, AlabamaAges 18 years+ - NCT07349537RecruitingPhase 1
Study of RMC-5127 for advanced KRAS G12V-mutant solid tumors
This trial tests a new drug called RMC-5127 for people with advanced solid tumors that have a specific KRAS G12V mutation. The study aims to see if this targeted therapy can help when other treatments have stopped working or caused side effects.
New Haven, ConnecticutAges 18 years+ - NCT07351045RecruitingPhase 3
Study of enicepatide for weight loss in obesity or overweight
This study tests a new injectable medication called enicepatide for people with obesity or overweight who have not been able to lose weight through diet and exercise alone. It may help you lose weight and improve health conditions linked to excess weight.
Anniston, AlabamaAges 18 years+ - NCT07350967Recruiting
Magnetic weight-loss procedure for diabetes or weight regain
This trial tests a new procedure that uses magnets to reroute part of your small intestine. It is for people with type 2 diabetes or who have had a sleeve gastrectomy and gained weight back. The goal is to see if this magnetic treatment can help with weight loss and diabetes control.
Ahmedabad, GujaratAges 25–65 - NCT07344220Enrolling by invitationPhase 2
Maintenance therapy study for stable metastatic pancreatic cancer
This trial tests a new drug, DZ-002, as maintenance therapy for people with metastatic pancreatic cancer whose disease has not worsened after at least 4 months of first-line chemotherapy. The goal is to help keep the cancer under control with fewer side effects.
Newport Beach, CaliforniaAges 18 years+ - NCT07350707RecruitingPhase 1/Phase 2
PET scan for Cushing's syndrome using two tracers
This trial tests if a special PET scan using two different tracers (68Ga-Pentixafor and 68Ga-DOTATATE) can help diagnose Cushing's syndrome and find its cause. It may help doctors better understand your condition and guide treatment.
Beijing, Beijing MunicipalityAges 10–80 - NCT07344701Recruiting
Screening for diabetes and heart disease risk in Ascoli Piceno
This study screens people in Ascoli Piceno for early signs of diabetes and heart disease and offers prevention steps. It's for people turning 50 in 2026 who haven't already had both diabetes and a major heart problem.
Ascoli Piceno, Ascoli PicenoAges 50–50 - NCT07352527Recruiting
New blood test for adrenal nodule diagnosis
This trial is testing a new method (using a blood test that measures steroid hormones) to better diagnose whether adrenal nodules are causing mild hormone problems. It may help doctors decide if you need treatment or just monitoring.
PessacAges 18 years+ - NCT07350694Recruiting
Community action to prevent and control type 2 diabetes in Kabul
This trial tests whether a community-led learning and action program can help prevent and control type 2 diabetes and its risk factors in adults. People with normal blood sugar, prediabetes, or diabetes are all welcome to join.
Kabul, KabulAges 20 years+ - NCT07345143Enrolling by invitation
AI study for gestational diabetes
This trial uses artificial intelligence to help manage gestational diabetes in pregnant women. It may improve care for women diagnosed early in pregnancy.
São José do Rio Preto, São PauloAges 18–40 - NCT07348146Enrolling by invitation
Hand-sewn vs. stapled bowel connection in SADI-S surgery
This trial compares two ways of reconnecting the intestine during SADI-S weight-loss surgery: one done by hand and one using staples. The goal is to see which method leads to fewer early problems after surgery, like leaks or infections.
CairoAges 18–70 - NCT07348432Recruiting
Insulin delivery and eating behaviors in type 1 diabetes
This study looks at how different insulin delivery methods (like injections or pumps) affect eating behaviors in people with type 1 diabetes. By joining, you may help researchers learn how to improve care and quality of life.
Montreal, QuebecAges 12 years+ - NCT07345832Recruiting
Volunteer-led lifestyle program for older adults with muscle loss
This study tests a volunteer-led program to improve muscle health in older adults with sarcopenia. It uses a mobile app to guide exercise and nutrition, and aims to see if this approach helps people regain strength.
Hong KongAges 60 years+ - NCT07347080RecruitingEarly Phase 1
Study of a new RNA-based drug for type 2 diabetes
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
Luoyang, HenanAges 18–65 - NCT07349290Enrolling by invitation
Vitamin D fortified foods for families
This trial tests if eating foods with extra vitamin D can improve vitamin D levels in families. It provides study foods and checks your vitamin D through blood samples.
ColeraineAges 4 years+ - NCT07349654Recruiting
New stent method to reduce brain fog after TIPS procedure
This trial tests a modified stent placement technique during TIPS (a procedure to lower blood pressure in the liver) to see if it helps prevent confusion and memory problems that can happen afterward.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07351214Enrolling by invitation
Mindfulness support for weight regain after slimming surgery
This trial tests if motivational interviewing combined with mindfulness can help patients manage weight regain after weight loss surgery. You may qualify if you regained weight at least 6 months after surgery.
AnkaraAges Any age - NCT07351318Enrolling by invitation
Insulin sensitivity in type 1 diabetes pregnancies
This study looks at how well the body uses insulin in women who had type 1 diabetes during a recent pregnancy. If you used a Dexcom CGM and Tandem insulin pump while pregnant, your data could help researchers better understand insulin needs in pregnancy.
Chicago, IllinoisAges 18 years+ - NCT07352618Enrolling by invitation
Omega-3 supplements for blood sugar and cholesterol in type 2 diabetes
This study tests whether adding omega-3 supplements to your regular diabetes treatment can improve blood sugar control and cholesterol. It may help people with type 2 diabetes who are already on medication.
DhakaAges 25–75 - NCT07351786Recruiting
Newer diabetes drugs and eye protection study
This trial is looking at whether newer diabetes drugs (like SGLT2 inhibitors and DPP-4 inhibitors) can help protect the eyes of people with long-standing type 2 diabetes. The study focuses on preventing or slowing diabetic retinopathy, a common eye complication.
AlexandriaAges 25 years+ - NCT07346079RecruitingPhase 4
Corticotropin gel for acute gout flares
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
Boston, MassachusettsAges 18–90 - NCT07344012Recruiting
Parenting hopes in women with Turner syndrome
This study looks at women with Turner syndrome who wanted to become parents. It aims to understand what support they received and what happened with their parenting plans.
StrasbourgAges 18–40 - NCT07351110Recruiting
Cervical cancer prevention for women with obesity or diabetes
This trial tests a program to help women with obesity or type 2 diabetes get cervical cancer screenings. It uses text messages or emails to remind and support you in getting screened.
Gainesville, FloridaAges 25 years+
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,616 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,939 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.